Shishir Chundawat from Rutgers Chemical and Biochemical Engineering has been elected by the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Technical Activities Committee for a one year period starting in March 2023. The Technical Activities Committee (TAC), led by NIIMBL Senior Fellow and appointed Co-Chairs, are responsible for NIIMBL’s technical priorities and road-mapping initiatives to ensure technical projects meet the current and future needs of the biopharmaceutical industry.
NIIMBL is a public-private partnership whose mission is to accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in this industry. NIIMBL is part of Manufacturing USA®, a diverse network of federally-sponsored manufacturing innovation institutes, and is funded through a cooperative agreement with the National Institute of Standards and Technology (NIST) in the U.S. Department of Commerce with significant additional support from its members.
Details about NIIMBL are available online: https://niimbl.force.com/s/